Cue Biopharma, Inc. Shares Outstanding (Cover Page)
Cue Biopharma, Inc. (CUE) had Shares Outstanding (Cover Page) of 7.26 million shares as of 2026-08-12, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-12: Entity Common Stock, Shares Outstanding 7.26M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 4.05M shares.
- 2026-03-13: Entity Common Stock, Shares Outstanding 97.66M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 78.74M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 7.26M shares 10-Q · filed 2026-08-14 |
| 2026-05-12 | 4.05M shares 10-Q · filed 2026-05-14 |
| 2026-03-13 | 97.66M shares 10-K · filed 2026-03-16 |
| 2025-11-07 | 78.74M shares 10-Q · filed 2025-11-12 |
| 2025-08-08 | 76.85M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 75.35M shares 10-Q · filed 2025-05-12 |
| 2025-03-27 | 61.82M shares 10-K · filed 2025-03-31 |
| 2024-11-10 | 63.35M shares 10-Q · filed 2024-11-14 |
| 2024-08-09 | 48.64M shares 10-Q · filed 2024-08-14 |
| 2024-05-06 | 48.64M shares 10-Q · filed 2024-05-09 |
| 2024-03-25 | 48.64M shares 10-K · filed 2024-03-28 |
| 2023-11-01 | 45.12M shares 10-Q · filed 2023-11-03 |
| 2023-08-01 | 44.96M shares 10-Q · filed 2023-08-08 |
| 2023-05-01 | 43.18M shares 10-Q · filed 2023-05-09 |
| 2023-03-13 | 43.17M shares 10-K · filed 2023-03-21 |
| 2022-11-01 | 35.39M shares 10-Q · filed 2022-11-14 |
| 2022-08-01 | 35.38M shares 10-Q · filed 2022-08-04 |
| 2022-05-02 | 35.37M shares 10-Q · filed 2022-05-10 |
| 2022-03-07 | 33.01M shares 10-K · filed 2022-03-16 |
| 2021-11-01 | 31.76M shares 10-Q · filed 2021-11-09 |
| 2021-08-02 | 31.51M shares 10-Q · filed 2021-08-09 |
| 2021-05-03 | 31.41M shares 10-Q · filed 2021-05-10 |
| 2021-03-01 | 30.46M shares 10-K · filed 2021-03-09 |
| 2020-11-02 | 30.28M shares 10-Q · filed 2020-11-09 |
| 2020-08-03 | 29.50M shares 10-Q · filed 2020-08-07 |
| 2020-05-01 | 28.43M shares 10-Q · filed 2020-05-07 |
| 2020-03-06 | 26.58M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 22.99M shares 10-Q · filed 2019-11-07 |
| 2019-08-01 | 22.58M shares 10-Q · filed 2019-08-08 |
| 2019-05-01 | 20.78M shares 10-Q · filed 2019-05-08 |
| 2019-03-07 | 20.73M shares 10-K · filed 2019-03-14 |
| 2018-11-08 | 20.13M shares 10-Q · filed 2018-11-13 |
| 2018-08-08 | 20.13M shares 10-Q · filed 2018-08-13 |
| 2018-05-09 | 20.13M shares 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |